RxDoctor Payments DataLook up a doctor →

POLIVY: payments to doctors

Payments that named POLIVY as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$4.4M
Providers
7,149
Transactions
19,687
Average per transaction
$225

The per-transaction average — $225 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,149 providers the average total is $621, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Genentech, Inc.$2,421,34154.6%
Genentech USA, Inc.$1,962,80144.2%
F. Hoffmann-la Roche AG$38,8820.9%
Hoffmann-la Roche Limited$14,6330.3%
← All drugs & devices